Osteoporosis Foundation of New Mexico Santa Fe Bone Symposium 2023

Comprehensive Updates in Osteoporosis, Metabolic Bone Disease, Bone Turnover Markers, DXA Interpretation, and Rare Skeletal Disorders

Osteoporosis Foundation of New Mexico Santa Fe Bone Symposium 2023 is a premier educational program dedicated to the diagnosis, prevention, and management of osteoporosis and metabolic bone diseases. Widely recognized as one of the most practical and clinically relevant bone health meetings in the United States, the symposium brings together internationally renowned experts to discuss emerging research, controversial topics, and evidence-based approaches to improving skeletal health.

The 23rd Annual Santa Fe Bone Symposium focuses on the theme “Progress and Controversies”, addressing challenging clinical scenarios frequently encountered in everyday practice. Through expert-led lectures, case-based discussions, and multidisciplinary perspectives, participants gain practical guidance on osteoporosis treatment sequencing, bone turnover markers, DXA interpretation, fracture prevention, cancer-related bone disease, and the management of rare skeletal disorders.

Course Overview

As the burden of osteoporosis and fragility fractures continues to rise worldwide, healthcare professionals must stay current with rapidly evolving diagnostic tools, treatment options, and clinical guidelines. Managing bone health has become increasingly complex due to expanding therapeutic choices, new evidence regarding treatment duration, and the need for individualized patient care.

The Santa Fe Bone Symposium bridges the gap between cutting-edge research and real-world clinical practice by providing practical recommendations that clinicians can immediately apply when managing patients with osteoporosis, metabolic bone disorders, and fracture risk.

The program combines foundational bone biology with advanced clinical management strategies, helping practitioners navigate difficult treatment decisions and optimize long-term skeletal outcomes.

Included Content

• 18 Video Lectures
• 18 Audio Recordings
• 18 Subtitle Files (.vtt)
• Expert Faculty Presentations
• Clinical Case Discussions

Total Size: 16.11 GB

Conference Dates: August 4–5, 2023

Location: Santa Fe, New Mexico, USA

Comprehensive Curriculum

Osteoporosis Management

Participants review:

• Osteoporosis diagnosis
• Fracture risk assessment
• Primary fracture prevention
• Secondary fracture prevention
• Long-term treatment strategies
• Individualized therapy selection
• Monitoring treatment response

Faculty provide practical guidance for managing patients across the osteoporosis spectrum.

Treatment Sequencing Strategies

Extensive instruction covers:

• Anabolic therapies
• Antiresorptive therapies
• Sequential treatment approaches
• Transitioning between therapies
• Optimizing treatment outcomes
• Preventing rebound bone loss
• Long-term management planning

Participants learn evidence-based approaches to treatment sequencing and therapeutic transitions.

Bisphosphonate Drug Holidays

Topics include:

• Duration of treatment
• Candidate selection
• Fracture risk reassessment
• Monitoring during treatment interruption
• Restarting therapy
• Clinical controversies

The symposium explores one of the most debated topics in osteoporosis management.

Bone Turnover Markers

Comprehensive sessions review:

• CTX (C-terminal telopeptide)
• P1NP (Procollagen Type 1 N-Terminal Propeptide)
• Clinical applications
• Treatment monitoring
• Adherence assessment
• Drug efficacy evaluation
• Interpretation of results

Faculty emphasize practical use of biomarkers in everyday clinical practice.

DXA and Bone Densitometry Updates

Coverage includes:

• DXA interpretation
• Bone mineral density assessment
• Fracture risk prediction
• International Society for Clinical Densitometry (ISCD) updates
• Official position statements
• Reporting standards
• Quality assurance

Participants gain updated knowledge regarding densitometry best practices.

Metabolic Bone Diseases

The course provides detailed reviews of:

• Osteomalacia
• Hyperparathyroidism
• Hypoparathyroidism
• Secondary osteoporosis
• Bone metabolism disorders
• Calcium and phosphate regulation

Clinical management strategies are emphasized throughout.

Rare Skeletal Disorders

Specialized sessions focus on:

Hypophosphatasia (HPP)

• Recognition and diagnosis
• Clinical manifestations
• Adult presentations
• Treatment considerations

X-Linked Hypophosphatemia (XLH)

• Pathophysiology
• Diagnosis
• Management strategies
• Emerging therapies

Hypoparathyroidism

• Diagnostic evaluation
• Long-term management
• New treatment approaches

Participants learn to recognize and manage uncommon but clinically important disorders.

Bone Health in Special Populations

Coverage includes:

Premenopausal Osteoporosis

• Evaluation strategies
• Secondary causes
• Treatment considerations

Pregnancy and Lactation-Associated Osteoporosis

• Risk factors
• Diagnostic challenges
• Management approaches

Cancer Treatment-Induced Bone Loss (CTIBL)

• Oncology-related bone complications
• Prevention strategies
• Therapeutic interventions

Faculty discuss the unique challenges associated with these patient populations.

Fracture Prevention Programs

Topics include:

• Fracture Liaison Services (FLS)
• Secondary fracture prevention
• Multidisciplinary care models
• Healthcare system implementation
• Quality improvement initiatives

Participants learn practical approaches to reducing fracture risk.

Bone Health and Orthopedic Surgery

Sessions review:

• Bone optimization before surgery
• Spine surgery considerations
• Fusion outcomes
• Fracture healing
• Surgical risk reduction

Project ECHO and Knowledge Dissemination

The symposium highlights:

• Project ECHO initiatives
• Expanding specialty knowledge
• Rural healthcare education
• Collaborative care models
• Community outreach strategies

Learning Objectives

Upon completion of this course, participants will be able to:

• Apply evidence-based strategies for osteoporosis diagnosis and treatment.
• Utilize bone turnover markers effectively in clinical practice.
• Implement treatment sequencing strategies to optimize outcomes.
• Manage bisphosphonate drug holidays appropriately.
• Interpret DXA studies using current ISCD recommendations.
• Recognize and treat rare skeletal disorders such as HPP and XLH.
• Address bone health challenges in cancer patients and special populations.
• Improve fracture prevention through multidisciplinary approaches.
• Integrate emerging evidence into metabolic bone disease management.
• Optimize long-term skeletal health outcomes.

Educational Features

✔ Internationally Recognized Bone Health Experts

✔ Osteoporosis Treatment Updates

✔ Bone Turnover Marker Education

✔ DXA Interpretation Training

✔ ISCD Guideline Updates

✔ Rare Bone Disease Reviews

✔ Fracture Prevention Strategies

✔ Cancer-Related Bone Disease Management

✔ Case-Based Clinical Discussions

✔ Practical Evidence-Based Recommendations

Target Audience

This course is designed for:

• Endocrinologists
• Rheumatologists
• Geriatricians
• Internal Medicine Physicians
• Osteoporosis Specialists
• Bone Densitometry Technologists
• Fracture Liaison Service Coordinators
• Orthopedic Surgeons
• Nurse Practitioners
• Physician Assistants
• Healthcare Professionals Managing Bone Disease

Why This Course Matters

Osteoporosis and metabolic bone diseases represent a major source of morbidity, disability, and healthcare costs worldwide. Clinicians face increasingly complex decisions regarding treatment selection, therapy duration, fracture prevention, and management of rare skeletal disorders.

Osteoporosis Foundation of New Mexico Santa Fe Bone Symposium 2023 delivers practical, evidence-based education designed to help healthcare professionals navigate these challenges while improving patient outcomes through optimized diagnosis, individualized treatment, and comprehensive bone health management.

+ Topics

The 2023 agenda featured a mix of didactic lectures and panel debates:

• Therapeutics & Guidelines:

  • Transitions and Holidays in Osteoporosis Therapy (Michael McClung, MD)

  • Controversies in Vitamin D (John Bilezikian, MD)

  • ISCD Official Positions Update (Bill Leslie, MD)

• Clinical Conundrums:

  • Spine Surgery and Bone Health (Mark Prasarn, MD)

  • Premenopausal, Pregnancy, and Lactation-Associated Osteoporosis (Christopher Kovacs, MD)

  • Nutrition and Skeletal Health: Updates and Controversies (Deborah Sellmeyer, MD)

• Basic Science & Genetics:

  • Basic Bone Biology for Clinicians (Teresita Bellido, PhD)

  • Update on Genetic Testing for Skeletal Diseases (Brendan Lee, MD)

• Oncology:

  • Cancer Treatment Induced Bone Loss in Breast and Prostate Cancer (Azeez Farooki, MD)